Low Dose Iron Chelation as TReatment of Oxidative Damage in Sickle Cell Disease
Clinical trial NCT05392101 · COMPLETED
Trial details
- NCT number
- NCT05392101
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-20
- Primary completion
- 2022-08-20
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.